A phase three clinical trial determined that a 3-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.
Click here for original story, Three-drug combo improves lung function in most common genetic form of cystic fibrosis
Source: ScienceDaily